Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer
Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer
About this item
Full title
Author / Creator
Publisher
Melbourne, Australia: Blackwell Publishing Asia
Journal title
Language
English
Formats
Publication information
Publisher
Melbourne, Australia: Blackwell Publishing Asia
Subjects
More information
Scope and Contents
Contents
The aim of the present study was to investigate the safety and immune responses of personalized peptide vaccination when administered with gemcitabine (GEM) in advanced pancreatic cancer (APC) patients. Thirteen patients with APC were enrolled. Pre‐vaccination with peripheral blood mononuclear cells and plasma was carried out to examine cellular an...
Alternative Titles
Full title
Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11158493
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11158493
Other Identifiers
ISSN
1347-9032
E-ISSN
1349-7006
DOI
10.1111/j.1349-7006.2007.00429.x
